Vi, the AI powering health enterprises that serve more than 190 million people, today announced the release of three State of AI 2026 reports: Healthcare, Biopharma, and Wellness. These three industry reports offer one of the most comprehensive views to date of how AI is shifting from experimentation to core enterprise infrastructure across the global health economy.
Drawing on industry research, emerging architectures, and Vi’s work across health enterprises, the reports reveal a clear pattern: AI has moved beyond prediction and is now the execution layer—identifying friction, triggering interventions, and autonomously completing multi-step workflows.
In Healthcare, agentic AI now orchestrates end-to-end operational workflows once handled by large support teams – accelerating care-gap closure, reducing administrative burden, and improving patient activation. Early adopters report 10–20% higher scheduling response, 20–50% no-show reduction, and 30–40% documentation lift. By 2028, over 80% of routine workflows may be AI-operated.
In Biopharma, AI is becoming the operating layer across commercial, medical, and clinical functions. Multi-agent orchestration drives 10–35% HCP activation gains, 2–3× faster evidence synthesis, 15–30% adherence lift, and 10–20% fewer enrollment delays—reshaping end-to-end lifecycle performance.
In Wellness, AI is replacing static programs with continuously adaptive systems. Agentic platforms report 3–6× KPI improvements, 20–50% lower churn, 40–60% reduced support load, and measurable biometric gains such as +18% deep-sleep duration.
“Our industry is moving from experimenting with AI to operating on it,” said Omri Yoffe, CEO of Vi. “Health Operators are deploying intelligence that can predict, decide, and act – at scale.”
“At Vi, we believe key industry lessons and know-how should be shared, not shelved. We’ve structured these reports in shareable format for real-world application and will continue making them accessible across our platforms. If you have a specific use case in mind, simply reach out.”
Vi’s Enterprise AI platform helps leading health organizations drive measurable performance and better health outcomes. Our platform transforms how enterprises activate, engage, and operate — turning data science into tangible patient- and enterprise-level ROI through a transparent, privacy-safe and seamlessly integrated AI orchestration layer.
Today, Vi powers real-world impact at a national scale:
- 190M+ patients and members supported in achieving healthier outcomes
- $2B+ in measurable value generated for Healthcare, Pharma, and Wellness clients
- 50+ life-changing therapies advanced across oncology, pediatric epilepsy, diabetes, and more
Vi enables health enterprises to deliver precision, speed, and operational excellence with AI they can trust, measure, and scale safely.
Headquartered in New York City and with teams in Tel Aviv, Boston, Austin, and Nashville, Vi remains committed to leveraging technology and data science to help people live better, healthier lives.
For Additional Information:
For further insights and to access ‘The State of AI in Biopharma Report’, ‘The State of AI in Healthcare Report’, and ‘The State of AI in Wellness Report 2026, visit Vi
media@vi.co
Vi Labs
